Allergy and the gut

International Archives of Allergy and Immunology

Volumn 121, Issue 4, 2000, Pages 270-283

  Bischoff, Stephan C ^a   Mayer, Julika H ^a   Manns, Michael P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Eosinophils; Food allergy; Inflammatory bowel disease; Interleukin 4; Intestinal allergy; Irritable bowel syndrome; Mast cells

Indexed keywords

ALLERGEN; ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 4; INTERLEUKIN 5; OKT 4; RECEPTOR ANTIBODY;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ALLERGIC REACTION; ALLERGY; CELIAC DISEASE; CROHN DISEASE; DIARRHEA; DIET RESTRICTION; ENDOSCOPY; ENTERITIS; ENTEROPATHY; EOSINOPHIL; FOOD ALLERGY; HUMAN; INTESTINE; IRRITABLE COLON; MAST CELL; MAST CELL DEGRANULATION; NAUSEA; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; SYMPTOM; ULCERATIVE COLITIS; VOMITING;

EID: 0034056866     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024340     Document Type: Review

References (100)

1. Finn R: Food allergy - fact or fiction: A review. J R Soc Med 1992;85:560-564.
2. Bischoff SC, Herrmann A, Manns MP: Prevalence of adverse reactions to food in patients with gastrointestinal disease. Allergy 1996;51: 811-818.
3. Sampson HA: Food allergy. Part I: Immunopathogenesis and clinical disorders. J Allergy Clin Immunol 1999;103:717-728.
4. Jones VA, Dickinson RJ, Workman E, Wilson AJ, Freeman AH, Hunter JO: Crohn's disease: Maintenance of remission by diet. Lancet 1985;ii:177-180.
5. Ballegaard M, Bjergstrom A, Bronndum S, Hylander E, Jensen L: Self-reported food intolerance in chronic inflammatory bowel disease. Scand J Gastroenterol 1997;32:569-571.
6. Zwetschenbaum JF, Burakoff R: Food allergy and the irritable bowel syndrome. Am J Gastroenterol 1988;83:901-904.
7. Young E, Stoneham MD, Petruckevitch A, Barton J, Rona R: A population study of food intolerance. Lancet 1994;343:1127-1130.
8. Kristjansson I, Ardal B, Jonsson JS, Sirudsson JA, Foldevi M, Bjorksten B: Adverse reaction to food and food allergy in young children in Iceland and Sweden. Scand J Prim Health Care 1999;17:30-34.
9. Bock SA: Prospective appraisal of complaints of adverse reactions to foods in children during the first 3 years of life. Pediatrics 1987;79:683-688.
10. Host A, Halken S: A prospective study of cow milk allergy in Danish infants during the first 3 years of life. Clinical course in relation to clinical and immunological type of hypersensitivity reaction. Allergy 1990;45:587-596.
11. Bishop JM, Hill DJ, Hosking CS: Natural history of cow milk allergy: Clinical outcome. J Pediatr 1990;116:862-867.
12. Bischoff SC: Mucosal allergy: Role of mast cells and cosinophil granulocytes in the gut. Baillière's Clin Gastroenterol 1996;10:443-459.
13. Bruijnzeel-Koomen C, Ortolani C, Aas K, Bindslev-Jensen C, Björkstén B, Moneret-Vautrin D, Wüthrich B: Adverse reactions to food. Allergy 1995;50:623-635.
14. Bischoff SC, Mayer J, Wedemeyer J, Meier PN, Zeck-Kapp G, Wedi B, Kapp A, Cetin Y, Gebel M, Manns MP: Colonoscopic allergen provocation (COLAP): A new diagnostic approach for gastrointestinal food allergy. Gut 1997;40:745-753.
15. Bischoff SC, Mayer J, Meier PN, Zeck-Kapp G, Manns MP: Clinical significance of the colonoscopic allergen provocation test. Int Arch Allergy Immunol 1997;113:348-351.
16. Podolsky D: Inflammatory bowel disease. Part 1. N Engl J Med 1991;325:928-937.
17. Podolsky D: Inflammatory bowel disease. Part 2. N Engl J Med 1991;325:1008-1018.
18. Hed J: Coeliac disease: A food allergy? Monogr Allergy. Basel, Karger, 1996, vol 32, pp 204-210.
19. Talley NJ, Shorter RG, Phillips SF, Zinsmeister AR: Eosinophilic gastroenteritis: A clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut 1990;31:54-58.
20. Naylor AR: Eosinophilic gastroenteritis. Scott Med J 1990;35:163-165.
21. Ebner C, Hirschwehr R, Bauer L, Breiteneder H, Valenta R, Ebner H, Kraft D, Scheiner O: Identification of allergens in fruits and vegetables: IgE cross-reactivities with the important birch pollen allergens Bet v 1 and Bet v 2 (birch profilin). J Allergy Clin Immunol 1995;95: 962-969.
22. Fritsch R, Bohle B, Vollmann U, Wiedermann U, Jahn-Schmid B, Krebitz M, Breiteneder H, Kraft D, Ebner C: Bet v 1, the major birch pollen allergen, and Mal d 1, the major apple allergen, cross-react at the level of allergen-specific T helper cells. J Allergy Clin Immunol 1998;102:679-686.
23. Valenta R, Duchene M, Ebner C, Valent P, Silaber C, Deviller P, et al: Profilins constitute a novel family of functional plant pan-allergens. J Exp Med 1992;175:377-385.
24. Vrtala S, Hirtenlehner K, Susani M, Hufnagl P, Binder BR, Vangelisla L, Pastore A, Sperr WR, Valent P, Ebner C, Kraft D, Valenta R: Genetic engineering of recombinant hypoallergenic oligomers of the major birch pollen allergen. Bet v 1: Candidates for specific immunotherapy. Int Arch Allergy Immunol 1999;118:218-219.
25. Crowe SE, Perdue MH: Gastrointestinal food hypersensitivity: Basic mechanisms of pathophysiology. Gastroenterology 1992;103:1075-1095.
26. Bischoff SC, Dahinden CA: c-kit ligand: A unique potentiator of mediator release by human lung mast cells. J Exp Med 1992;175:237-244.
27. Galli SJ, Tsai M, Wershil BK: The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others. Am J Pathol 1993;142:965-974.
28. Bischoff SC, Dahinden CA: Effect of c-kil ligand on mediator release by human lung mast cells. Int Arch Allergy Immunol 1992;99:319-322.
29. Bischoff SG, Schwengberg S, Wordelmann K, Weimann A, Raab R, Manns MP: Effect of c-kit ligand, stem cell factor, on mediator release by human intestinal mast cells isolated from patients with inflammatory bowel disease and controls. Gut 1996;38:104-114.
30. Bischoff SC, Schwengberg S, Raab R, Manns MP: Functional properties of human intestinal mast cells cultured in a new culture system. Enhancement of IgE receptor-dependent mediator release and response to stem cell factor. J Immunol 1997;159:5560-5567.
31. Valent P, Besmer J, Sillaber CH, Butlerfield JH, Eher R, Majdic O, Kishi K, Kleptko W, Eckersberger F, Kaltenrunner R, Lechner K, Bettelheim P: Failure to detect IL-3 binding sites on human mast cells. J Immunol 1990; 145:3432-3437.
32. Bischoff SC, Sellge A, Lorentz A, Sebald W, Raab R, Manns MP: Interleukin-4 enhances proliferation and mediator release in mature human mast cells. Proc Natl Acad Sci USA 1999;96:8080-8085.
33. Brunner T, Heusser CH, Dahinden CA: Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J Exp Med 1993;177:605-611.
34. Dvorak AM, Monahan RA, Osage JE, Dickersin GR: Mast-cell degranulation in Crohn's disease. Lancet 1978:i:498.
35. Strobel S, Busuttil A, Ferguson A: Human intestinal mucosal mast cells: Expanded population in untreated coeliac disease. Gut 1983; 24:222-227.
36. Patrick MK, Dunn IJ, Buret A, Miller HRP, Huntley JF, Gibson S, Gall DG: Mast cell protease release and mucosal ultrastructure during intestinal anaphylaxis in the rat. Gastroenterology 1988;94:1-9.
37. Reimann HJ, Lewin J: Gastric mueosal reactions in patients with food allergy. Am J Gastroenterol 1988;11:1212-1219.
38. Bagnato GF, Di Cesare E, Caruso RA, Gulli S, Cugliari A, Morabito Lo Prete A, Previti M, Muscara M, Bottari M: Gastric mucosal mast cells in atopic subjects. Allergy 1995;50:322-327.
39. D'Inca R, Ramage JK, Hunt RH, Perdue MH: Antigen-induced mucosal damage and restitution in the small intestine of the immunized rat. Int Arch Allergy Appl Immunol 1990;91: 270-277.
40. Gordon JR, Burd PR, Galli SJ: Mast cells as a source of multifunctional cytokines. Immunol Today 1990;11:458-464.
41. Echtenacher B, Männel DN, Hultner L: Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996;381:75-77.
42. Malaviya R, Ikeda T, Ross E, Abraham SN: Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 1996;381:77-80.
43. Bischoff SC, Lorentz A, Schwengberg S, Weier G, Raab R, Manns MP: Mast cells are an important cellular source of tumour necrosis factor alpha in human intestinal tissue. Gut 1999;44:643-652.
44. Lorentz A, Schwengberg S, Mierke C, Manns MP, Bischoff SC: Human intestinal mast cells produce IL-5 in vitro upon IgE receptor cross-linking and in vivo in the course of intestinal inflammatory disease. Eur J Immunol 1999;29: 1496-1503.
45. Lorentz A, Schwengberg S, Sellge G, Manns MP, Bischoff SC: Human intestinal mast cells are capable of producing different cytokine profiles: Role of IgE receptor cross-linking and IL-4. J Immunol 2000;164:43-48.
46. Miyajima I, Dombrowicz D, Martin TR, Ravetch JV, Kinet JP, Galli SJ: Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and FcγRIII. J Clin Invest 1997; 99:901-914.
47. Iikura M, Takaishi T, Hirai K, Yamada H, Iida M, Koshino T, Morita Y: Exogenous nitric oxide regulates the degranulation of human basophils and rat peritoneal mast cells. Int Arch Allergy Immunol 1998;115:129-136.
48. Joos GF, Lefebre RA, Bullock GR, Pauwels RA: Role of 5-hydroxytryptamine and mast cells in the tachykinin-induced contraction of rat trachea in vitro. Eur J Pharmacol 1997;338: 259-268.
49. Suzuki R, Furuno T, McKay DM, Wolvers D, Teshima R, Nakanishi M, Bienenstock J: Direct neurite-mast cell communication in vitro occurs via the neuropeptide substance P. J Immunol 1999;163:2410-2415.
50. Bonini S, Lambiase A, Bonini S, Angelucci F, Magrini L, Manni L, Aloe L: Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. Proc Natl Acad Sci USA 1996;93:10955-10960.
51. Marshall JS, Gomi K, Blennerhassett MG, Bienenstock J: Nerve growth factor modifies the expression of inflammatory cytokines by mast cells via a prostanoid-dependent mechanism. J Immunol 1999;167:4271-4276.
52. Nilsson G, Forsberg-Nilsson K, Xiang Z, Hallbook F, Nilsson K, Metcalfe DD: Human mast cells express functional TrkA and are a source of nerve growth factor. Eur J Immunol 1997; 27:2295-2301.
53. Castagliuolo I, Wang CC, Valenick L, Pasha A, Nikulasson S, Carraway RE, Pothoulakis C: Neurotensin is a proinflammatory neuropeptide in colonic inflammation. J Clin Invest 1999;103:843-849.
54. Furuta GT, Ackerman SJ, Wershil BK: The role of the cosinophil in gastrointestinal diseases. Curr Opin Gastroenterol 1995;11:541-547.
55. Levy AM, Kita K: The eosinophil in gut inflammation: Effector or director? Gastroenterology 1996;110:952-954.
56. Dvorak AM: Ultrastructural evidence for release of major basic protein-containing crystalline cores of eosinophil granules in vivo: Cytotoxic potential in Crohn's disease. J Immunol 1980;125:460-462.
57. Raab Y, Fredens K, Gerdin B, Hällgren R: Eosinophil activation in ulcerative colitis. Dig Dis Sci 1998;43:1061-1070.
58. Levy AM, Gleich GJ, Sandborn WJ, Tremaine WJ, Steiner ML, Phillips SF: Increased eosinophil granule proteins in gut lavage fluid from patients with inflammatory bowel disease. Mayo Clin Proc 1997;72:117-123.
59. Bischoff SC, Grabowsky J, Manns MP: Quantification of inflammatory mediators in stool samples of patients with inflammatory bowel disorders and controls. Dig Dis Sci 1997;42: 394-403.
60. Bischoff SC, Mayer JH, Nguyen Q-T, Stolte M, Manns MP: Immunohistochemical assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease. Am J Gastroenterol 1999;94:3521-3529.
61. Berstad A, Borkje B, Riedel B, Elsayed S, Berstad A: Increased fecal eosinophil cationic protein in inflammatory bowel disease. Hepatogastroenterology 1993;40:276-278.
62. Rothenberg ME: Eosinophilia. N Engl J Med 1998;338:1592-1600.
63. Kosa L, Kereki E, Borzsonyl L: Copro-eosinophil cationic protein (ECP) in food allergy. Allergy 1996;51:964-966.
64. Bengtsson U, Knutson TW, Knutson L, Dannaeus A, Hällgren R, Ahlstedt S: Eosinophil cationic protein and histamine after intestinal challenge in patients with cow's milk intolerance. J Allergy Clin Immunol 1997;100:216-221.
65. Raible DG, Schulman ES, DiMuzio J, Cardillo R, Post TJ: Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils. J Immunol 1992;148:3536-3542.
66. Gounni AS, Lamkhioued B, Delaporte E, Dubost A, Kinet JP, Capron A, Capron M: The high-affinity IgE receptor on eosinophils: From allergy to parasites or from parasites to allergy? J Allergy Clin Immunol 1994;94:1214-1216.
67. Capron M, Gounni SA, Morita M, Truong MJ, Prin L, Kinet JP, Capron A: Eosinophils: From low- to high-affinity immunoglobulin E receptors. Allergy 1995;50(suppl 25):20-23.
68. Bischoff SC, Brunner T, de Weck AL, Dahinden CA: Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists. J Exp Med 1990;172:1577-1582.
69. Bischoff SC, de Weck AL, Dahinden CA: Interleukin 3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a. Proc Natl Acad Sci USA 1990;87:6813-6817.
70. Takafuji S, Bischoff SC, de Weck AL, Dahinden CA: IL-3 and IL-5 prime normal human eosinophils to produce leukotriene C4 in response to soluble agonists. J Immunol 1991; 147:3855-3861.
71. Takafuji S, Bischoif SC, de Weck AL, Dahinden CA: Opposing effects of tumor necrosis factor-alpha and nerve growth factor upon leukotriene C4 production by human eosinophils triggered with N-formyl-methionyl-leucyl-phenylalanine. Eur J Immunol 1992;22:969-974.
72. Rot A, Krieger M, Brunner T, Bischoff SC, Schall TJ, Dahinden CA: RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J Exp Med 1992;176: 1489-1495.
73. Bischoff SC, Krieger M, Brunner T, Rot A, von Tscharner V, Baggiolini M, Dahinden CA: RANTES and related chemokines activate human basophil granulocytes through different G protein-coupled receptors. Eur J Immunol 1993;23:761-767.
74. Baggiolini M, Dahinden CA: CC chemokines in allergic inflammation. Immunol Today 1994;15:127-133.
75. Alam R, Grant JA: The chemokines and the histamine-releasing factors: Modulation of function of basophils, mast cells and eosinophils. Chem Immunol 1995;61:148-160.
76. Rollins BJ: Chemokines. Blood 1997;90:909-928.
77. Sallusto F, Lanzavecchia A, Mackay CR: Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 1998;19:568-574.
78. Kay AB, Ying S, Varney V, Gaga M, Durham SR, Moqbel R, Wardlaw AJ, Hamind Q: Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5 and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 1991;173:775-778.
79. Kolmannskog S, Haneberg B: Immunoglobin E in feces from children with allergy. Int Arch Allergy Appl Immunol 1985;76:133-137.
80. Sampson HA: Food allergy. Part 2: Diagnosis and management. J Allergy Clin Immunol 1999;103:981-989.
81. Bengtsson U, Nilsson-Balknäs U, Hanson LÅ, Ahlstedt S: Double blind, placebo controlled food reactions do not correlate to IgE allergy in the diagnosis of staple food related gastrointestinal symptoms. Gut 1996;39:130-135.
82. Belut D, Moneret-Vautrin DA, Nicolas JP, Grilliat JP: IgE levels in intestinal juice. Dig Dis Sci 1980;25:323-332.
83. Huggins KG, Brostoff J: Local production of specific IgE antibodies in allergic-rhinitis patients with negative skin tests. Lancet 1975;ii: 148-150.
84. Andre F, Andre C, Colin L, Cavagna S: IgE in stools as indicator of food sensitization. Allergy 1995;50:328-333.
85. Sampson HA, Broadbent KR, Bernhisel-Broadbent J: Spontaneous release of histamine from basophils and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity. N Engl J Med 1989;321:228-232.
86. Nolte H, Stahl-Skov P, Kruse A, Schiotz PO: Histamine release from dispersed human intestinal mast cells. A method using biopsies from children and adults. Allergy 1989;44:543-553.
87. De Week AL, Stadler BM, Urwyler A, Wehner HU, Bühlmann RP: Cellular allergen stimulation test (CAST) - a new dimension in allergy diagnostics. ACI News 1993;5:9-14.
88. Rossi RE, Monasterolo G, Operti D: A comparative study of the tryptase release test and the cellular allergen stimulation test (CAST) in mite sensitive patients. Clin Exp Allergy 1998; 28:752-757.
89. Raithel M, Matek M, Baenkler HW, Jorde W, Hahn EG: Mucosal histamine content and histamine secretion in Crohn's disease, ulcerative colitis and allergic enteropathy. Int Arch Allergy Immunol 1995;108:127-133.
90. van Necrven RJJ, Ebner C, Yssel H, Kapsenberg ML, Lamb JR: T-cell responses to allergens: Epitope-specificity and clinical relevance. Immunol Today 1996;17:526-532.
91. Nicodemus C, Philip G, Jones N, Hirani S, Norman P: Integrated clinical experience with tolerogcnic peptides. Int Arch Allergy Immunol 1997;113:326-328.
92. ® anti-CD4 monoclonal antibody. SB210396 (IDEC CE9.1). on CD4+ T lymphocytes in chronic severe asthma. J Allergy Clin Immunol 1998;101:S9.
93. Corne J, Djukanovic R, Thomas L, Warner J, Botta L, Grandordy B, Gygax D, Heusser C, Patalano F, Richardson W, Kilchherr E, Stachelin T, Davis F, Gordon W, Sun L, Liou R, Wang G, Chang TW, Holgate S: The effect of intravenous administration of achimeric anti-IgE antibody on serum IgE levels in atopic subjects: Efficacy, safety, and pharmacokinetics. J Clin Invest 1997;99:879-887.
94. Garlisi CG, Kung TT, Wang P, Minnicozzi M, Umland SP, Chapman RW, Stelts D, Crawley Y, Falcone A, Myers JG, Jones H, Billah MM, Kreutner W, Egan RW: Effects of chronic anti-interleukin-5 monoclonal antibody treatment in a murine model of pulmonary inflammation. Am J Respir Cell Mol Biol 1999;20:248-255.
95. Borish LC, Nelson HS, Lanz M, Claussen LR, Martin DW, Garrison L: Phase I/II study of interleukin-4 receptor (IL-4R) in moderate asthma. J Allergy Clin Immunol 1998;101: S8.
96. Vercelli D, De Monte L, Monticelli S, Di Bartolo C, Agresti A: To E or not to E? Can an IL-4-induced B cell choose between IgE and IgG4? Int Arch Allergy Immunol 1998;116:1-4.
97. Jenmalm MC, Bjorksten B, Macaubas C, Holt BJ, Smallacombe TB, Holt PG: Allergen-induced cytokine secretion in relation to atopic symptoms and immunoglobin E and immunoglobin G subclass antibody responses. Pediatr Allergy Immunol 1999;10: 168-177.
98. Barnes KC, Marsh DG: The genetics and complexity of allergy and asthma. Immunol Today 1998;19:325-332.
99. Anderson GG, Morrison JFJ: Molecular biology and genetics of allergy and asthma. Arch Dis Child 1998;78:488-494.
100. Thomas NS, Wilkinson J, Holgate ST: The candidate region approach to the genetics of asthma and allergy. Am J Respir Crit Care Med 1997;156:S144-151.